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Medical Science and 3) Department of Microbiology, College of Medicine, University of Dammam, AlKhobar, Saudi ArabiaAbstractCarbapenem-resistant Enterobacteriaceae (CRE) and carbapenem-resistant Pseudomonas aeruginosa (CRPAE) are globally a major medical
issue, especially in intensive care units. The digestive tract is the main reservoir for these isolates; therefore, rectal swab surveillance is
highly recommended. The purpose of this study was to detect the prevalence of gastrointestinal tract colonization of CRE and CRPAE in
patients admitted to intensive care units in Saudi Arabia. This project also aimed to characterize carbapenem-hydrolyzing enzyme
production in these isolates. From February to May 2015, 200 rectal swab specimens were screened by CHROMagar KPC. Organism
identiﬁcation and susceptibility testing were performed using the Vitek 2 system. One CRE and 13 CRPAE strains were identiﬁed, for a
prevalence of 0.5% (1/200) and 6.5% (13/200) respectively. Strains showed high genetic diversity using enterobacterial repetitive
intergenic consensus sequence-based PCR. NDM type and VIM type were detected by PCR in four and one CRPAE isolates respectively.
ampC overexpression was detected in eight CRPAE isolates using Mueller-Hinton agar containing 1000 μg/mL cloxacillin. CTX-M-15 type
was detected in 1 CRE by PCR. The prevalence of CRE strain colonization was lower than that of CRPAE isolates. The detection of
NDM and VIM in the colonizing CRPAE strains is a major infection control concern. To our knowledge, this is the ﬁrst study in Saudi
Arabia and the gulf region focusing on digestive tract colonization of CRE and CRPAE organisms and characterizing the mechanisms of
carbapenem resistance.
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E-mail: baha000@hotmail.comIntroductionEnterobacteriaceae and Pseudomonas aeruginosa are among the
most common organisms causing nosocomial infections
worldwide, especially in intensive care units (ICUs) [1–5]. The
treatment of these organisms became more difﬁcult because of
their production of extended-spectrum β-lactamases (ESBLs),
such as blaCTX-M, plasmid-mediated AmpC (pAmpC) orNew Microbes and New Infections © 2016 The Authors. Published by El
This is an open access artioverexpression of chromosomal ampC gene [6–10]. Carba-
penems became the last source for treatment of such organ-
isms, which in turn has led to the emergence of carbapenem
resistance under antibiotic selective pressure [8,11,12]. The
global spread of carbapenem-resistant, Gram-negative rods is
signiﬁcantly increasing [1,2,13]. Carbapenem resistance in
Gram-negative rods is mainly due to two mechanisms: ﬁrst the
production of carbapenem-hydrolyzing enzymes (i.e. serine-
carbapenemases and metallo-β-lactamases), and second the
combination of membrane impermeability with production of
ESBLs, pAmpC or ampC overexpression [2,8,11,13].
Carbapenem-hydrolyzing enzymes is the most alarming mech-
anism because genes encoding carbapenem resistance (i.e.
blaNDM, blaOXA-48, blaIMP, blaVIM, blaKPC) are carried out on
mobile DNA elements [8,14,15]. Therefore, they areNew Microbe and New Infect 2016; 10: 77–83
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major infection control concern worldwide [8,14,15]. Gener-
ally carbapenem resistance is associated with resistance to
other antibiotics such as aminoglycosides and ﬂuoroquinolones
in these organisms [11,15].
Carbapenem-resistant Enterobacteriaceae (CRE) and
carbapenem-resistant Pseudomonas aeruginosa (CRPAE) cause
ICU-acquired infections and are associated with high morbidity
and mortality rates [16,17]. Gastrointestinal ﬂora is the main
source of these organisms and can play a key role in the spread of
antibiotic resistance and ICU infections caused by CRE and
CRPAE [18–20]. In order to control their spread, good surveil-
lance and infection control programmes must be established to
identify the digestive colonization of these carbapenem-resistant
organisms. There are scanty data in the literature characterizing
the gastrointestinal colonization of these organisms [11,21]. In a
previous study, our group found that the prevalence of digestive
tract colonization of carbapenem-resistant Acinetobacter bau-
mannii was 6.2% [11]. To our knowledge, there are no studies
focusing on the prevalence of gastrointestinal tract colonization
of CRE or CRPAE in Saudi Arabia or in the other Gulf Cooper-
ation Council (GCC) countries.
The aim of the current study was to evaluate the prevalence
of intestinal carriage of CRE and CRPAE in patients admitted to
ICUs in Saudi Arabia. We also sought to characterize the
carbapenem-hydrolyzing genes produced by these organisms.Materials and MethodsStudy population and setting
This project was conducted in two hospitals in the Eastern
Province of Saudi Arabia: a 450-bed general hospital, King Fahad
University Hospital, in Khobar and a 650-bed tertiary-care
hospital, King Fahad Specialist Hospital, in Dammam. From
February 2015 to May 2015, nonrepetitive rectal swab speci-
mens were collected from ICU patients at admission in both
hospitals. Specimens were screened for CRE and CRPAE using
CHROMagar KPC as recommended by the manufacturer
(CHROMagar, Paris, France).
Organism identiﬁcation and antimicrobial
susceptibility testing
All colonies with colours speciﬁed by the manufacturer (pink,
red, cream, metallic blue, translucent) growing on CHROMagar
KPC were subcultured on blood agar plates and MacConkey
agar plates for further assessment. Organism identiﬁcation and
antimicrobial susceptibility testing for these strains were car-
ried out using the Vitek 2 automatic system (bioMérieux, Marcy
l’Étoile, France) according the manufacturer’s recommendation.New Microbes and New Infections © 2016 The Authors. Published by Elsevier Ltd on behalf of
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/liceThe Vitek 2 system was considered the reference standard
method in this study. Escherichia coli ATCC 25922 and Pseudo-
monas aeruginosa ATCC 27853 strains were used as controls
for antimicrobial susceptibility testing. Minimum inhibitory
concentrations (MIC) and breakpoints were determined ac-
cording to the guidelines of Clinical and Laboratory Standards
Institute (CLSI). Antibiotics tested in this study included imi-
penem (IMP), meropenem (MEP), gentamicin (GM), amikacin
(AK), ciproﬂoxacin (CIP), cefepime (FEP), cefotaxime (CTX),
ceftazidime (CAZ) and colistin (CO). In addition, ertapenem
(ERT) was tested for Enterobacteriaceae.
All strains conﬁrmed to be carbapenem resistant using the
Vitek 2 system were further tested phenotypically and by PCR.
For phenotypic detection of carbapenemases, Etest strips for
detection of metallo-β-lactamases (Etest MBL) were performed
as previously described [22,23]. Phenotypic testing for ESBL
production in CRE isolates was performed using double disk
synergy testing as previously described [16]. In addition, the
overexpression of the chromosomally encoded ampC gene in
the CRPAE organisms was tested by restoration of suscepti-
bility for ceftazidime using Mueller-Hinton agar plates contain-
ing 1000 μg/mL of cloxacillin [8].
Molecular characterization of β-lactamase-resistant
genes
PCR methodology was used for molecular characterization of
β-lactamase genes. All carbapenem-resistant strains were
tested for the presence of carbapenem-resistant genes (OXA-
48, NDM, IMP, VIM, KPC, SIM, SPM and GIM). CRE strains
were also tested for ESBL production including TEM, SHV and
CTX-M β-lactamases. In addition, CMY, DHA, FOX, EBC,
MOX and ACC β-lactamases were tested to detect the pro-
duction of pAmpC in CRE. Primers and PCR parameters were
used as previously described [21,24–28]. Positive controls
were used for all genes tested in this study. Molecular-grade
water was also used as a negative control to detect contami-
nation. Ampliﬁed amplicons were then sequenced using an ABI
3730xl DNA Analyzer (Applied Biosystems, Foster City, CA,
USA) as previously described [25,26,28].
Epidemiologic analysis of carbapenem-resistant strains
The relatedness of carbapenem-resistant strains was studied
using enterobacterial repetitive intergenic consensus sequence-
based PCR (ERIC-PCR) methodology using a protocol and
primers described by Rivera et al. [29]. Brieﬂy, genomic DNA
template was extracted using a standard heat boiling lysis
method. A pure single colony was inoculated in 10 mL of Luria-
Bertani broth with 0.5% NaCl (w/v) and incubated in incubator
shaker at 37°C with rotary speed at 250 rpm for 18 hours. The
overnight-grown bacterial culture was pelleted, resuspended inEuropean Society of Clinical Microbiology and Infectious Diseases, NMNI, 10, 77–83
nses/by-nc-nd/4.0/)
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100°C for 15 minutes, and centrifuged. A volume of 2 μL of the
supernatant was used for DNA ampliﬁcation. The ampliﬁcation
conditions were performed as follows: an initial denaturation
cycle at 94°C for 5 minutes, 35 cycles at 95°C for 1 minutes,
52°C for 1 minute and 72°C for 5 minutes, then a ﬁnal
extension at 72°C for 10 minutes. The ampliﬁed products were
analysed on a 1.5% agarose gel stained with ethidium bromide.
All gels were analysed using the gel Compar II 6.6 software
package (Applied Maths, Sint-Martens-Latem, Belgium). Den-
drograms for ERIC-PCR gels were generated using the Dice
similarity coefﬁcient and the unweighted-pair group method
using arithmetic (unweighted pair group method with arith-
metic mean, UPGMA) averages, with 1% optimization and 1%
position tolerance [30].
Statistical analysis
Categorical variable comparison was determined by two-tailed
Fisher’s exact test; p <0.05was considered statistically signiﬁcant.ResultsA total of 200 nonduplicated rectal swab specimens were
screened at ICU admission during the 4-month period of theTABLE 1. Epidemiology and antimicrobial susceptibility testing
Sample no. Organism ID
Age
(years) Sex IMP MEP ERT FE
Carbapenem-resistant Enterobacteriaceae and Pseudomonas aeruginosa
1 Klebsiella pneumoniae 8 M R R R R
2 P. aeruginosa 30 F R R NA R
3 P. aeruginosa 35 M R I R
4 P. aeruginosa 61 M R R S
5 P. aeruginosa 19 M R R R
6 P. aeruginosa 2 F R R R
7 P. aeruginosa 3 F R R R
8 P. aeruginosa 40 M R R R
9 P. aeruginosa 2 M R R R
10 P. aeruginosa 61 M R R R
11 P. aeruginosa 74 M R R R
12 P. aeruginosa 66 M R R R
13 P. aeruginosa 44 M R R R
14 P. aeruginosa 76 M R R R
Carbapenem-susceptible Enterobacteriaceae and P. aeruginosa
15 Escherichia coli 20 M S S S S
16 E. coli 56 F S S S R
17 E. coli 47 F S S S R
18 K. pneumoniae 1 M S S S R
19 K. pneumoniae 6 M S S S R
20 K. pneumoniae 84 F S S S R
21 K. pneumoniae 77 M S S S R
22 Providencia stuartii 74 M S S S S
23 P. aeruginosa 52 M S S NA I
24 P. aeruginosa 76 F S S I
25 P. aeruginosa 58 F S S S
26 P. aeruginosa 30 M S S S
27 P. aeruginosa 72 F S S S
28 P. aeruginosa 47 M S S S
29 P. aeruginosa 84 F S S S
30 P. aeruginosa 31 M S S S
31 P. aeruginosa 66 M S S S
AK, amikacin; CAZ, ceftazidime; CIP, ciproﬂoxacin; CO, colistin; CTX, cefotaxime; ERT, er
applicable; R, resistant; S, susceptible.
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43.8 years (range, 1–84 years). A total of 31 strains were
isolated using CHROMagar KPC as a screening method. Of
these 31 strains, only 14 strains (one Klebsiella pneumoniae and
13 P. aeruginosa) were carbapenem resistant using the reference
standard method, the Vitek 2 system (Table 1). Seventeen
strains screened by CHROMagar KPC out of the 31 strains
were carbapenem susceptible by Vitek 2 (Table 1). Therefore,
the overall prevalence of CRE and CRPAE strains colonizing the
patients admitted to the ICU units was 7% (14/200). The
prevalence of CRE and CRPAE was 0.5% (1/200) and 6.5% (13/
200) respectively. The rate of carbapenem resistance in these
isolates was 45.1% (14/31). The highest susceptibility rate was
for colistin (100%, 31/31), followed by aminoglycosides (ami-
kacin 23/31, 74.2%, and gentamicin 22/31, 71%) (Table 2). The
susceptibility rates were 32.3% (10/31), 29% (9/31), 25.8% (8/
31) and 13% (4/31) for cefepime, ceftazidime, ciproﬂoxacin and
cefotaxime respectively. Using Fisher’s exact test, carbapenem
resistance was statistically signiﬁcantly associated with more
resistance to amikacin, gentamicin, cefepime and ceftazidime
with p values of less than 0.05 (Table 2). However, it was not
the case for ciproﬂoxacin, cefotaxime and colistin, where p
values were more than 0.05 (Table 2).
Etest MBL was positive for 5 CRPAE strains. The phenotypic
conﬁrmatory test for ESBLs was positive for the carbapenem-P CTX CAZ GM AK CIP CO Carbapenemase
R R S S S S CTX-M-15 type
R R R R R S VIM type
R R R R R S ampC overexpression
R S S S S S
R R S S S S
R R S S R S
R R S S S S
R R R R R S NDM type
R R S S S S ampC overexpression
R R R R R S NDM type
R R R R R S NDM type
R R R R R S ampC overexpression
R R S S R S
R R R R R S NDM type
S S S S S S NA
R R S S R S
R R R S R S
R R S S S S
R I S S S S
R R S S S S
R R S S S S
R R R S S S
R S S R I S NA
R R S S S S
R S S S S S
R S S S S S
R S S S S S
S S S S S S
S S S S S S
S S S S S S
R S S S S S
tapenem; FEP, cefepime; GM, gentamicin; IMP, imipenem; MEP, meropenem; NA, not
f of European Society of Clinical Microbiology and Infectious Diseases, NMNI, 10, 77–83
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TABLE 2. Association of carbapenem resistance and non-β-lactam antibiotics
Antibiotic
Carbapenem-resistant Enterobacteriaceae
and Pseudomonas aeruginosa (n [ 14)
Carbapenem-susceptible Enterobacteriaceae and
P. aeruginosa (n [ 17)
Total
susceptibility rate
pS (%) R (%) S (%) R (%) S (%)
Gentamicin 7 7 15 2 22/31 (71) 0.04
Amikacin 7 7 16 1 23/31 (74.2) 0.01
Ciproﬂoxacin 5 9 3 14 8/31 (25.8) 0.4
Cefepime 1 13 9 8 10/31 (32.3) 0.008
Cefotaxime 0 14 4 13 4/31 (13) 0.1
Ceftazidime 1 13 8 9 9/31 (29) 0.02
Colistin 14 0 17 0 31/31 (100) 1.0
R, resistant; S, susceptible.
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ceftazidime was restored for eight of 13 CRPAE strains using
Mueller-Hinton agar plates containing cloxacillin.
PCR tests for CRPAE strains revealed a 497 bp amplicon
correlating with NDM in four strains and a 382 bp amplicon
using VIM primers in one strain. NDM and VIM types were
conﬁrmed by sequencing. For the CRKP isolate, a 415 bp PCR
amplicon correlating with CTX-M-15 type was detected and
revealed by sequencing. PCRs using pAmpC primers were
negative for CRKP. No PCR ampliﬁcation was detected for
TEM, SHV, OXA-48, IMP, KPC, SIM, SPM and GIM.
Using ERIC-PCR methodology, the 22 strains of P. aeruginosa
were grouped into six clusters and three single isolates at 90%
similarity level (Fig. 1). Enterobacteriaceae strains were grouped
into two clusters and one single isolate at 91% similarity level
(Fig. 2). The dendrogram of Enterobacteriaceae strains exhibited
discriminatory capability by producing a species-speciﬁc cluster
that discriminated K. pneumoniae from E. coli and Providencia
stuartii. However, three strains of P. aeruginosa and one strain of
Enterobacteriaceae demonstrated no genetic correlation (Figs. 1
and 2). No outbreaks caused by carbapenem-resistant Gram-
negative rods were reported in either hospital during the study
period. In addition, routine environmental sampling did not
detect any carbapenem-resistant organisms.DiscussionDigestive tract colonization by carbapenem-resistant Gram-
negative bacilli is a critical step before the development of
nosocomial infections such as bloodstream infections, urinary
tract infections and ventilator-associated infections
[1,16,17,21]. Therefore, early and accurate detection of colo-
nized patients will help reduce the spread of such organisms. In
addition, rectal swab specimens are the most appropriate
specimens because the reservoir of these organisms is the
gastrointestinal tract [1,5,7,18].New Microbes and New Infections © 2016 The Authors. Published by Elsevier Ltd on behalf of
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/liceIn this study, the prevalence of colonization of CRE in the ICU
patients at admission was 0.5%. This is low compared to other
countries in the Middle East such as Morocco (13%), India (9.9%)
and Pakistan (18.3%). However, it is comparable to studies in
Korea (0.3%) [12,19,31,32]. In addition, the prevalence of colo-
nization of CRPAE is 6.5%,which is lower than studies performed
in Spain (12%) and higher than those in France (3.4%) [8,13,33].
CRPAE ismore prevalent thanCRE. Thismay be due to the ability
of P. aeruginosa to rapidly develop antimicrobial resistance
through acquisition of resistant genes or throughmodiﬁcations of
antibiotic targets by mutations [13,33]. The prevalence study of
these organisms is signiﬁcant from infection-control standpoint;
it will also help in developing protocols of antibiotic use, especially
for gastrointestinal tract surgeries.
In our study, the production of carbapenem-hydrolyzing
enzymes was detected in ﬁve isolates of P. aeruginosa strains.
Our data correlate with other studies in the GCC states
[34–37]. The production of carbapenemases in Enter-
obacteriaceae and P. aeruginosa is an emerging problem in the
GCC region. OXA-48 and NDM-1 are the most common
carbapenemases produced in Enterobacteriaceae, and to a lesser
extent KPC, VIM-4 and OXA-181 [34]. MBLs are the most
common mechanism causing carbapenem resistance in
P. aeruginosa in Saudi Arabia and the GCC states, with VIM
being the most prevalent MBL [34,35]. All these studies re-
ported carbapenemase genes harboured by Enterobacteriaceae
and P. aeruginosa strains causing different types of infections.
However, our study characterizes the mechanisms of carba-
penem resistance in colonizing strains.
Carbapenem resistance was associated with CTX-M-15
production in a CRKP strain and ampC overexpression in
eight isolates of CRPAE. It is well known that ESBLs or ampC
can lead to carbapenem resistance when coupled with porin
mutations [8–10]. Therefore, it is possible that ESBL and ampC
genes in these strains might be associated with porin mutations,
resulting in carbapenem resistance. This is supported by the fact
that ceftazidime susceptibility was restored in the presence ofEuropean Society of Clinical Microbiology and Infectious Diseases, NMNI, 10, 77–83
nses/by-nc-nd/4.0/)
FIG. 1. ERIC-PCR methodology for Pseudomonas aeruginosa strains. ampC, ampC overexpression; ERIC-PCR, enterobacterial repetitive intergenic
consensus sequence-based PCR; NA, not applicable; SN, strain number.
NMNI Abdalhamid et al. CRE and P. aeruginosa in Saudi Arabia 81cloxacillin in eight CRPAE isolates. To our knowledge, ours is
the ﬁrst study in the GCC states to report the involvement of
ampC overexpression in CRPAE isolates. The molecular
epidemiology using ERIC-PCR demonstrated high genetic di-
versity among these isolates. These data, taken together, sug-
gest that each strain has a unique pathway of emergence ofFIG. 2. ERIC-PCR methodology for Enterobacteriaceae strains. ERIC-PCR, en
strain number. Klebsiella pneumoniae SN 1 is carbapenem-resistant Enterobact
New Microbes and New Infections © 2016 The Authors. Published by Elsevier Ltd on behal
This is an open access articarbapenem resistance. CRPAE strains producing VIM and
NDM are of particular concern because these genes are
generally harboured on mobile DNA elements that can be
transmitted from patient to patient in a hospital setting.
It is possible that ampC overexpression in these CRPAE
isolates was due to overuse of β-lactam agents such asterobacterial repetitive intergenic consensus sequence-based PCR; SN,
eriaceae.
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antibiotics over the counter is a common practice throughout
the Middle East, which makes it a big source of the emergence
of antimicrobial resistance. It is also possible to develop car-
bapenem resistance under selective pressure of carbapenem
use because it is also common to initiate carbapenem therapy as
an empirical treatment in this region. Therefore, carbapenem-
susceptible P. aeruginosa strains colonizing ICU patients are a
major concern. These strains are able to acquire resistance
mechanisms either by horizontal transmission from patient to
patient or by selection of mutants. Several reports have
conﬁrmed the development of carbapenem resistance in sus-
ceptible P. aeruginosa strains in the hospital setting [1,5,7,8]. A
study characterizing the determining risk factors for the
acquisition of carbapenem resistance in Gram-negative bacilli in
ICU patients and other wards of the hospital is in progress.
There are a few limitations to our study. Despite the statistical
signiﬁcance of ourﬁndings, the studywas conducted on a relatively
small number of specimens. In addition, we screened only rectal
swabs; other anatomic sites can be colonized by carbapenem-
resistant Gram-negative rods, and these sites should not be
ignored. Therefore, we are in the process of conducting a larger
epidemiologic study collecting specimens from different anatomic
sites from patients in the ICU and other hospital wards.
To our knowledge, this is the ﬁrst study characterizing the
digestive tract colonization of CRE and CRPAE isolates in pa-
tients admitted to the ICU in Saudi Arabia and the gulf region.
The data presented here clearly demonstrate the prevalence of
these organisms in our patients. It also emphasizes the need for
strong infection-control programs to detect the digestive tract
colonization of carbapenem-resistant Gram-negative bacilli; the
need to reduce the overuse of carbapenems; and the need to
establish good antimicrobial stewardship programs.AcknowledgementsThe authors thank Z. AlQahtani, King Fahad Specialist Hospital,
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